
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Revenue | -- | -- | $8.3B | $9.7B | $10.7B | |
Revenue Growth (YoY) | -- | -- | 7.04% | 16.61% | 11.1% | |
Cost of Revenues | -- | -- | $7.2B | $8B | $8.8B | |
Gross Profit | -- | -- | $1.1B | $1.7B | $2B | |
Gross Profit Margin | -- | -- | 12.73% | 17.4% | 18.35% | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | -- | -- | $662.8M | $810.4M | $852.4M | |
Other Inc / (Exp) | -- | -- | -$60.5M | $13.8M | -$47.4M | |
Operating Expenses | -- | -- | $674.4M | $843.2M | $907.1M | |
Operating Income | -- | -- | $380M | $837.6M | $1.1B | |
Net Interest Expenses | -- | -- | $43.9M | $53.8M | $111.9M | |
EBT. Incl. Unusual Items | -- | -- | $275.6M | $797.6M | $903M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | -- | $97.5M | $190M | $210M | |
Net Income to Company | -- | -- | $173.9M | $598M | $681.4M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -- | -- | $173.9M | $598M | $681.4M | |
Basic EPS (Cont. Ops) | -- | -- | $2.65 | $9.15 | $10.41 | |
Diluted EPS (Cont. Ops) | -- | -- | $2.63 | $9.08 | $10.35 | |
Weighted Average Basic Share | -- | -- | $65.7M | $65.4M | $65.5M | |
Weighted Average Diluted Share | -- | -- | $66.1M | $65.9M | $65.8M | |
EBITDA | -- | -- | $436.6M | $1B | $1.2B | |
EBIT | -- | -- | $329M | $866.2M | $1B | |
Revenue (Reported) | -- | -- | $8.3B | $9.7B | $10.7B | |
Operating Income (Reported) | -- | -- | $380M | $837.6M | $1.1B | |
Operating Income (Adjusted) | -- | -- | $329M | $866.2M | $1B |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $1.9B | $1.9B | $2.3B | $2.5B | $2.3B | |
Revenue Growth (YoY) | 5.14% | 3% | 16.57% | 12.16% | -9.08% | |
Cost of Revenues | $1.6B | $1.7B | $1.9B | $2.1B | $1.9B | |
Gross Profit | $315.1M | $201.3M | $333.8M | $470M | $399.9M | |
Gross Profit Margin | 16.68% | 10.35% | 14.72% | 18.48% | 17.29% | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $172M | $169.2M | $199.1M | $196.8M | $211M | |
Other Inc / (Exp) | $3.1M | $1.1M | $5.8M | -$2M | $500K | |
Operating Expenses | $174.3M | $172M | $203M | $210.3M | $224.5M | |
Operating Income | $140.8M | $29.3M | $130.8M | $259.7M | $175.4M | |
Net Interest Expenses | $11.2M | $11.6M | $7.2M | $20.8M | $25M | |
EBT. Incl. Unusual Items | $132.7M | $18.8M | $129.4M | $236.9M | $150.9M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $33.2M | $20.2M | $34.2M | $54.7M | $36.8M | |
Net Income to Company | $99.6M | -$2.1M | $88.5M | $179.4M | $112.2M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $99.6M | -$2.1M | $88.5M | $179.4M | $112.2M | |
Basic EPS (Cont. Ops) | $1.45 | -$0.03 | $1.35 | $2.73 | $1.73 | |
Diluted EPS (Cont. Ops) | $1.44 | -$0.03 | $1.34 | $2.71 | $1.72 | |
Weighted Average Basic Share | $68.5M | $66.4M | $65.4M | $65.7M | $64.8M | |
Weighted Average Diluted Share | $69.3M | $66.4M | $65.8M | $66.1M | $65.1M | |
EBITDA | $166.2M | $57.8M | $173.3M | $305.9M | $231.5M | |
EBIT | $144.5M | $31.4M | $142.8M | $259.3M | $177.9M | |
Revenue (Reported) | $1.9B | $1.9B | $2.3B | $2.5B | $2.3B | |
Operating Income (Reported) | $140.8M | $29.3M | $130.8M | $259.7M | $175.4M | |
Operating Income (Adjusted) | $144.5M | $31.4M | $142.8M | $259.3M | $177.9M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $6.8B | $8B | $8.6B | $9.9B | $10.5B | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $5.7B | $6.9B | $7.4B | $8.1B | $8.6B | |
Gross Profit | $1.1B | $1.1B | $1.2B | $1.8B | $1.9B | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $607.2M | $669.2M | $692.7M | $808.1M | $866.6M | |
Other Inc / (Exp) | $10M | -$8.2M | -$55.8M | $6M | -$44.9M | |
Operating Expenses | $613.4M | $680.8M | $705.4M | $850.5M | $921.3M | |
Operating Income | $478.8M | $402.7M | $481.5M | $966.5M | $978M | |
Net Interest Expenses | $41.9M | $45.5M | $39.5M | $67.4M | $116.1M | |
EBT. Incl. Unusual Items | $446.9M | $349M | $386.2M | $905.1M | $817M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $99.3M | $5.8M | $111.5M | $210.5M | $192.1M | |
Net Income to Company | $346.3M | $343.9M | $264.5M | $688.9M | $614.2M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $346.3M | $343.9M | $264.5M | $688.9M | $614.2M | |
Basic EPS (Cont. Ops) | $5.12 | $4.48 | $3.82 | $10.52 | $9.41 | |
Diluted EPS (Cont. Ops) | $5.08 | $4.43 | $3.79 | $10.45 | $9.36 | |
Weighted Average Basic Share | ||||||
Weighted Average Diluted Share | ||||||
EBITDA | $596.5M | $507.6M | $552.1M | $1.2B | $1.1B | |
EBIT | $494.6M | $398.5M | $440.4M | $982.7M | $941.1M | |
Revenue (Reported) | $6.8B | $8B | $8.6B | $9.9B | $10.5B | |
Operating Income (Reported) | $478.8M | $402.7M | $481.5M | $966.5M | $978M | |
Operating Income (Adjusted) | $494.6M | $398.5M | $440.4M | $982.7M | $941.1M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $1.9B | $1.9B | $2.3B | $2.5B | $2.3B | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $1.6B | $1.7B | $1.9B | $2.1B | $1.9B | |
Gross Profit | $315.1M | $201.3M | $333.8M | $470M | $399.9M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $172M | $169.2M | $199.1M | $196.8M | $211M | |
Other Inc / (Exp) | $3.1M | $1.1M | $5.8M | -$2M | $500K | |
Operating Expenses | $174.3M | $172M | $203M | $210.3M | $224.5M | |
Operating Income | $140.8M | $29.3M | $130.8M | $259.7M | $175.4M | |
Net Interest Expenses | $11.2M | $11.6M | $7.2M | $20.8M | $25M | |
EBT. Incl. Unusual Items | $132.7M | $18.8M | $129.4M | $236.9M | $150.9M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $33.2M | $20.2M | $34.2M | $54.7M | $36.8M | |
Net Income to Company | $99.6M | -$2.1M | $88.5M | $179.4M | $112.2M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $99.6M | -$2.1M | $88.5M | $179.4M | $112.2M | |
Basic EPS (Cont. Ops) | $1.45 | -$0.03 | $1.35 | $2.73 | $1.73 | |
Diluted EPS (Cont. Ops) | $1.44 | -$0.03 | $1.34 | $2.71 | $1.72 | |
Weighted Average Basic Share | $68.5M | $66.4M | $65.4M | $65.7M | $64.8M | |
Weighted Average Diluted Share | $69.3M | $66.4M | $65.8M | $66.1M | $65.1M | |
EBITDA | $166.2M | $57.8M | $173.3M | $305.9M | $231.5M | |
EBIT | $144.5M | $31.4M | $142.8M | $259.3M | $177.9M | |
Revenue (Reported) | $1.9B | $1.9B | $2.3B | $2.5B | $2.3B | |
Operating Income (Reported) | $140.8M | $29.3M | $130.8M | $259.7M | $175.4M | |
Operating Income (Adjusted) | $144.5M | $31.4M | $142.8M | $259.3M | $177.9M |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | -- | -- | $805.9M | $125.4M | $204.9M | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | -- | -- | $1.2B | $1.3B | $1.3B | |
Inventory | -- | -- | $1.9B | $2.1B | $2.3B | |
Prepaid Expenses | -- | -- | -- | -- | -- | |
Other Current Assets | -- | -- | $90.7M | $93.6M | $114.5M | |
Total Current Assets | -- | -- | $4.5B | $4.5B | $4.5B | |
Property Plant And Equipment | -- | -- | $1.1B | $1.3B | $1.5B | |
Long-Term Investments | -- | -- | $63.1M | $55.6M | $48.1M | |
Goodwill | -- | -- | $1B | $1.4B | $1.4B | |
Other Intangibles | -- | -- | $457M | $830.2M | $777.6M | |
Other Long-Term Assets | -- | -- | $17.4M | $32.1M | $38M | |
Total Assets | -- | -- | $7.7B | $9.1B | $9.4B | |
Accounts Payable | -- | -- | $1.1B | $1.2B | $1.1B | |
Accrued Expenses | -- | -- | $119.5M | $242.5M | $246.2M | |
Current Portion Of Long-Term Debt | -- | -- | -- | -- | $2.3M | |
Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
Other Current Liabilities | -- | -- | $373.4M | $442.7M | $446.5M | |
Total Current Liabilities | -- | -- | $2.4B | $3.1B | $3B | |
Long-Term Debt | -- | -- | $595M | $597.5M | $599.5M | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | -- | -- | $4.5B | $5.4B | $5.3B | |
Common Stock | -- | -- | $700K | $700K | $700K | |
Other Common Equity Adj | -- | -- | -$92.3M | -$72M | -$103.2M | |
Common Equity | -- | -- | $3.2B | $3.7B | $4.2B | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | -- | -- | $3.2B | $3.7B | $4.2B | |
Total Liabilities and Equity | -- | -- | $7.7B | $9.1B | $9.4B | |
Cash and Short Terms | -- | -- | $805.9M | $125.4M | $204.9M | |
Total Debt | -- | -- | $604.7M | $772.5M | $961.8M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $1.1B | $944.5M | $538.7M | $69.9M | $210.3M | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | $877.1M | $987.4M | $1.3B | $1.5B | $1.4B | |
Inventory | $1.4B | $1.5B | $1.9B | $2.2B | $2.5B | |
Prepaid Expenses | -- | -- | -- | -- | -- | |
Other Current Assets | $153.2M | $64.5M | $87.1M | $91.7M | $107M | |
Total Current Assets | $4B | $4.3B | $4.4B | $4.7B | $4.9B | |
Property Plant And Equipment | $561.2M | $603.7M | $871.5M | $1.1B | $1.2B | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | $1.1B | $1B | $1.1B | $1.4B | $1.4B | |
Other Intangibles | $447.3M | $464.9M | $536.1M | $812.8M | $765.1M | |
Other Long-Term Assets | $267.7M | $436.3M | $326.9M | $359.9M | $390.9M | |
Total Assets | $6.3B | $7B | $7.9B | $9.5B | $9.8B | |
Accounts Payable | $662.3M | $982.3M | $1.1B | $1.1B | $970.1M | |
Accrued Expenses | $185.6M | $138.5M | $146.9M | $158.4M | $173.4M | |
Current Portion Of Long-Term Debt | -- | -- | -- | -- | $2.5M | |
Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
Other Current Liabilities | $329.3M | $348.8M | $379M | $428.3M | $415.5M | |
Total Current Liabilities | $1.9B | $2.4B | $2.5B | $3.3B | $2.7B | |
Long-Term Debt | $818.3M | $594.4M | $595.2M | $598.9M | $1.1B | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $3.3B | $4B | $4.7B | $5.6B | $5.5B | |
Common Stock | $700K | $700K | $700K | $700K | $700K | |
Other Common Equity Adj | -$183.9M | -$133.9M | -$83.3M | -$89.6M | -$68.7M | |
Common Equity | -- | -- | -- | -- | -- | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | $3B | $3B | $3.2B | $3.8B | $4.2B | |
Total Liabilities and Equity | $6.3B | $7B | $7.9B | $9.5B | $9.8B | |
Cash and Short Terms | $1.1B | $944.5M | $538.7M | $69.9M | $210.3M | |
Total Debt | $818.3M | $594.4M | $597.3M | $1.2B | $1.5B |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -- | -- | $173.9M | $598M | $681.4M | |
Depreciation & Amoritzation | -- | -- | $107.6M | $159.9M | $200.1M | |
Stock-Based Compensation | -- | -- | $28.6M | $31.9M | $38.1M | |
Change in Accounts Receivable | -- | -- | -$346.7M | -$184.6M | $200.9M | |
Change in Inventories | -- | -- | -$330.8M | -$116.1M | -$112.4M | |
Cash From Operations | -- | -- | $601.3M | $599.6M | $550.1M | |
Capital Expenditures | -- | -- | $269.5M | $325.3M | $281M | |
Cash Acquisitions | -- | -- | -$19.7M | -$963.2M | -$114.3M | |
Cash From Investing | -- | -- | -$300.4M | -$1.3B | -$388.8M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -$97.3M | -$107.2M | -$120M | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | -- | -- | $10.4M | $1.6B | $4.3B | |
Long-Term Debt Repaid | -- | -- | -$225M | -$1.5B | -$4.1B | |
Repurchase of Common Stock | -- | -- | -$155M | -$22.5M | -$116M | |
Other Financing Activities | -- | -- | -$18.1M | -$16.4M | -$22.9M | |
Cash From Financing | -- | -- | -$485M | $3.4M | -$75.1M | |
Beginning Cash (CF) | -- | -- | $995.7M | $805.9M | $125.4M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -- | -- | -$184.1M | -$682.6M | $86.2M | |
Ending Cash (CF) | -- | -- | $805.9M | $125.4M | $204.9M | |
Levered Free Cash Flow | -- | -- | $331.8M | $274.3M | $269.1M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $99.6M | -$2.1M | $88.5M | $179.4M | $112.2M | |
Depreciation & Amoritzation | $21.7M | $26.4M | $30.5M | $46.6M | $53.6M | |
Stock-Based Compensation | $8.3M | $6.8M | $6.8M | $8.7M | $8.2M | |
Change in Accounts Receivable | -- | -- | -- | -- | -- | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | $326.8M | $328.9M | $79.8M | -$355.8M | -$394.9M | |
Capital Expenditures | $18.9M | $28M | $111.5M | $100.1M | $40.3M | |
Cash Acquisitions | -$112.1M | -- | -$164.8M | -$7.8M | -$900K | |
Cash From Investing | -$122.3M | -$40.1M | -$277.1M | -$111.2M | -$43.1M | |
Dividends Paid (Ex Special Dividend) | -$22.7M | -$24.5M | -$26.8M | -$30.1M | -$32.9M | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | -- | $1.1B | $1.6B | |
Long-Term Debt Repaid | -- | -$225M | -$25M | -$667M | -$1.1B | |
Repurchase of Common Stock | -- | -$85.4M | -$15.2M | -$15.1M | -$28.7M | |
Other Financing Activities | -$1.2M | -$4.9M | -$4.1M | -$8.3M | -$16.3M | |
Cash From Financing | -$5.7M | -$337.9M | -$71.1M | $412.5M | $438.1M | |
Beginning Cash (CF) | $898.6M | $995.7M | $805.9M | $125.4M | $204.9M | |
Foreign Exchange Rate Adjustment | -$4.2M | -$2.1M | $1.2M | -$1M | $5.3M | |
Additions / Reductions | $198.8M | -$49.1M | -$268.4M | -$54.5M | $100K | |
Ending Cash (CF) | $1.1B | $944.5M | $538.7M | $69.9M | $210.3M | |
Levered Free Cash Flow | $307.9M | $300.9M | -$31.7M | -$455.9M | -$435.2M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $346.3M | $343.9M | $264.5M | $688.9M | $614.2M | |
Depreciation & Amoritzation | $101.9M | $109.1M | $111.7M | $176M | $207.1M | |
Stock-Based Compensation | $26.5M | $23.3M | $28.6M | $33.8M | $37.6M | |
Change in Accounts Receivable | -- | -- | -- | -- | -- | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | $957.4M | $692.5M | $352.2M | $164M | $511M | |
Capital Expenditures | $104.2M | $143.6M | $353M | $313.9M | $221.2M | |
Cash Acquisitions | -$115M | -$39.5M | -$184.5M | -$806.2M | -$107.4M | |
Cash From Investing | -$186.1M | -$168.8M | -$537.4M | -$1.1B | -$320.7M | |
Dividends Paid (Ex Special Dividend) | -$86.1M | -$94.6M | -$99.6M | -$110.5M | -$122.8M | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | -- | -- | $10.4M | $2.7B | $4.8B | |
Long-Term Debt Repaid | -$5.2M | -$225M | -$25M | -$2.1B | -$4.6B | |
Repurchase of Common Stock | -$10.2M | -$361.5M | -$84.8M | -$22.4M | -$129.6M | |
Other Financing Activities | -$4.2M | -$10.1M | -$17.3M | -$20.6M | -$30.9M | |
Cash From Financing | -$80.4M | -$666.6M | -$218.2M | $487M | -$49.5M | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $690.9M | -$142.9M | -$403.4M | -$468.7M | $140.8M | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | $853.2M | $548.9M | -$800K | -$149.9M | $289.8M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $99.6M | -$2.1M | $88.5M | $179.4M | $112.2M | |
Depreciation & Amoritzation | $21.7M | $26.4M | $30.5M | $46.6M | $53.6M | |
Stock-Based Compensation | $8.3M | $6.8M | $6.8M | $8.7M | $8.2M | |
Change in Accounts Receivable | -- | -- | -- | -- | -- | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | $326.8M | $328.9M | $79.8M | -$355.8M | -$394.9M | |
Capital Expenditures | $18.9M | $28M | $111.5M | $100.1M | $40.3M | |
Cash Acquisitions | -$112.1M | -- | -$164.8M | -$7.8M | -$900K | |
Cash From Investing | -$122.3M | -$40.1M | -$277.1M | -$111.2M | -$43.1M | |
Dividends Paid (Ex Special Dividend) | -$22.7M | -$24.5M | -$26.8M | -$30.1M | -$32.9M | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | -- | $1.1B | $1.6B | |
Long-Term Debt Repaid | -- | -$225M | -$25M | -$667M | -$1.1B | |
Repurchase of Common Stock | -- | -$85.4M | -$15.2M | -$15.1M | -$28.7M | |
Other Financing Activities | -$1.2M | -$4.9M | -$4.1M | -$8.3M | -$16.3M | |
Cash From Financing | -$5.7M | -$337.9M | -$71.1M | $412.5M | $438.1M | |
Beginning Cash (CF) | $898.6M | $995.7M | $805.9M | $125.4M | $204.9M | |
Foreign Exchange Rate Adjustment | -$4.2M | -$2.1M | $1.2M | -$1M | $5.3M | |
Additions / Reductions | $198.8M | -$49.1M | -$268.4M | -$54.5M | $100K | |
Ending Cash (CF) | $1.1B | $944.5M | $538.7M | $69.9M | $210.3M | |
Levered Free Cash Flow | $307.9M | $300.9M | -$31.7M | -$455.9M | -$435.2M |
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.